Literature DB >> 2399820

The epidemiology of demoralization in a kibbutz.

S Gilboa1, I Levav, L Gilboa, F Ruiz.   

Abstract

This article reports a true prevalence study of demoralization conducted in a kibbutz. This commune, which assures its members all their instrumental needs throughout the individual life span, is probably one of the few of its kind in the world. All adult members (n = 353) of a kibbutz affiliated with the most orthodox of the federations replied to a self-administered interview containing the Psychiatric Epidemiology Research interview 27-item Demoralization Scale. The response rate approached 95%. Univariate and multivariate analyses were conducted using demoralization rates and mean scores as dependent variables. The overall prevalence of demoralization was 25%. Women exhibited higher rates and mean scores. There was a clear association between occupational prestige scores and demoralization in both sexes. Discussion is based on the comparison between the study findings and those published in the literature, both in terms of the overall results and their pattern of association with key sociodemographic variables.

Entities:  

Mesh:

Year:  1990        PMID: 2399820     DOI: 10.1111/j.1600-0447.1990.tb01356.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

1.  Socio-economic status, employment and neurosis.

Authors:  B Rodgers
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1991-05       Impact factor: 4.328

2.  Socio-demographic and clinical features associated with demoralization in medically ill in-patients.

Authors:  Carlo Marchesi; Carlo Maggini
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-07-11       Impact factor: 4.328

3.  Development and validation of a mental health screening tool for asylum-seekers and refugees: the STAR-MH.

Authors:  Debbie C Hocking; Serafino G Mancuso; Suresh Sundram
Journal:  BMC Psychiatry       Date:  2018-03-16       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.